Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Copeland

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Drug and Alcohol Dependence|August 5, 2018
Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016Andrea H Weinberger, Lauren R Pacek, Melanie M Wall, et al.
JAMA Psychiatry|January 17, 2014
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trialDavid J Allsop, Jan Copeland, Nicholas Lintzeris, et al.
BMC Psychiatry|May 20, 2018
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocolAnjali K Bhardwaj, David J Allsop, Jan Copeland, et al.
JAMA Internal Medicine|July 16, 2019
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical TrialNicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, et al.
Psychiatry Research|June 10, 2023
Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational studyOvidiu Tatar, Amal Abdel-Baki, Alina Dyachenko, et al.
The Lancet. Psychiatry|September 12, 2015
Young adult sequelae of adolescent cannabis use: an integrative analysisEdmund Silins, L John Horwood, George C Patton, et al.
JMIR Research Protocols|November 25, 2022
Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC)Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Drug and Alcohol Dependence|August 5, 2018
Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016Andrea H Weinberger, Lauren R Pacek, Melanie M Wall, et al.
JAMA Psychiatry|January 17, 2014
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trialDavid J Allsop, Jan Copeland, Nicholas Lintzeris, et al.
BMC Psychiatry|May 20, 2018
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocolAnjali K Bhardwaj, David J Allsop, Jan Copeland, et al.
JAMA Internal Medicine|July 16, 2019
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical TrialNicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, et al.
Psychiatry Research|June 10, 2023
Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational studyOvidiu Tatar, Amal Abdel-Baki, Alina Dyachenko, et al.
The Lancet. Psychiatry|September 12, 2015
Young adult sequelae of adolescent cannabis use: an integrative analysisEdmund Silins, L John Horwood, George C Patton, et al.
JMIR Research Protocols|November 25, 2022
Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC)Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, et al.
Pageof 11